Shire's (SHPG) Vyvanse sNDA Accepted for Review by FDA
Tweet Send to a Friend
Shire plc (Nasdaq: SHPG) announced that the US Food and Drug Administration (FDA) has accepted for filing with priority review ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE